Register for our free email digests:
Talecris Biotherapeutics Inc.
Division of Grifols SA
www.talecris.com
Latest From Talecris Biotherapeutics Inc.
CNS IPOs Follow Broad Industry Trends
Datamonitor Healthcare's five-year review of initial public offerings of CNS-focused companies shows that they held their own compared with other biopharma sectors. The markets rewarded pain and neurodegenerative disease-focused players in particular. Step-up multiples in CNS IPOs slightly outpaced those for other biotechs.
Novartis Trims Its Sails, Divests Blood-Testing Unit To Spain’s Grifols
CEO Joe Jimenez delivers on his strategy to free up resources at Novartis by divesting its non-core blood transfusion diagnostics business for $1.7 billion.
Analysts Mixed As Australia’s CSL Moves To Settle U.S. Price Fixing Case
Australia’s CSL has probably made the right decision to settle a price-fixing lawsuit in the United States and thereby avoid a protracted legal battle that could have seen further substantial legal costs even if it eventually won. But the proposed settlement has some analysts concerned the legal basis for the lawsuit was thin as it stemmed from regulatory questions raised in a failed industry merger.
Grifols to begin trial of inhaled alpha1-proteinase inhibitor for CF
Spanish firm Grifols has announced plans to begin a safety trial of a next-generation inhaled formulation of alpha1-proteinase inhibitor later this year. The news follows the decision by the US FDA to grant orphan drug designation to the product for cystic fibrosis in April.
Company Information
- Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Non-Specific
- Alias(es)
- NPS BioTherapeutics Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Grifols SA
- Senior Management
-
Lawrence Stern, CEO
John M Hanson, EVP, CFO
Steve Petteway, PhD, EVP, R&D - Contact Info
-
Talecris Biotherapeutics Inc.
Phone: (919) 316-6300
4101 Research Commons
79 TW Alex. Dr.
P.O. Box 110526 Research Triangle Park, NC 27709
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice